BELLINI, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 9.310
EU - Europa 3.138
AS - Asia 1.733
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 11
OC - Oceania 10
SA - Sud America 3
Totale 14.218
Nazione #
US - Stati Uniti d'America 9.294
CN - Cina 1.104
UA - Ucraina 746
IT - Italia 618
TR - Turchia 495
DE - Germania 452
PL - Polonia 334
GB - Regno Unito 317
SE - Svezia 193
FI - Finlandia 190
AT - Austria 84
BE - Belgio 81
HK - Hong Kong 48
FR - Francia 38
VN - Vietnam 19
NL - Olanda 16
CA - Canada 14
IR - Iran 14
IN - India 13
KR - Corea 13
ES - Italia 12
RU - Federazione Russa 10
CZ - Repubblica Ceca 9
EU - Europa 9
SD - Sudan 9
AU - Australia 7
RO - Romania 7
MY - Malesia 6
BG - Bulgaria 5
JP - Giappone 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 3
DK - Danimarca 3
IQ - Iraq 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BR - Brasile 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
IE - Irlanda 2
MX - Messico 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
GE - Georgia 1
HR - Croazia 1
MK - Macedonia 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SG - Singapore 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 14.218
Città #
Woodbridge 1.184
Fairfield 986
Chandler 926
Jacksonville 882
Houston 690
Ann Arbor 684
Ashburn 484
Wilmington 409
Seattle 349
Warsaw 325
Izmir 309
Cambridge 299
Nanjing 254
Ferrara 216
Beijing 208
Princeton 207
Boardman 156
Dearborn 123
Nanchang 94
Milan 86
Shenyang 83
Brussels 79
San Diego 77
Addison 74
Vienna 64
Changsha 62
Shanghai 58
Hebei 52
Tianjin 52
Bremen 50
Jiaxing 46
Hong Kong 44
Jinan 34
Norwalk 33
Orange 32
New York 31
Ningbo 30
Redwood City 25
London 23
Helsinki 21
Kunming 21
Mountain View 21
Auburn Hills 20
Leawood 20
Guangzhou 19
Augusta 18
San Mateo 18
Dong Ket 17
Düsseldorf 17
Zhengzhou 17
Bologna 16
Falls Church 16
Los Angeles 15
Des Moines 13
Rome 12
Washington 11
Indiana 10
Brno 9
Ferrara di Monte Baldo 9
Haikou 9
Hefei 9
Kraków 9
Taizhou 9
Montréal 8
Munich 8
Tappahannock 8
Casalecchio Di Reno 7
Changchun 7
Hangzhou 7
Modena 7
Philadelphia 7
Saint Petersburg 7
Ardabil 6
Fuzhou 6
Torino 6
Lanzhou 5
Lübeck 5
Redmond 5
Sant'agata Sul Santerno 5
Sofia 5
Wageningen 5
Walnut 5
Chicago 4
Dronten 4
Hanover 4
Khartoum 4
Kilburn 4
Madrid 4
Shah Alam 4
Verona 4
Acton 3
Calderara Di Reno 3
Chisinau 3
Florence 3
Melbourne 3
Monmouth Junction 3
Niscemi 3
Ostiglia 3
Paris 3
Patiala 3
Totale 10.357
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 338
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 187
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 165
null 163
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 154
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 146
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 143
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 143
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 134
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 129
null 128
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 123
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 122
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 121
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 120
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 120
Activation of the sendai virus fusion protein by receptor binding 116
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 113
A rapid method for purification of myelin basic protein 110
null 110
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 110
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 109
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 109
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 109
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 109
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 108
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 107
Activation of the Sendai virus fusion protein by receptor binding 106
null 106
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 106
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 105
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 105
null 104
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 101
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 101
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 100
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 99
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor. 99
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 99
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 98
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 98
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 98
null 97
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 97
The effect of inorganic phosphate on the stability of some enzymes 93
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 93
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 91
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 90
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 89
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 88
null 88
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 87
Evaluation of a possible role of oxidative stress in climacteric symptoms. 87
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 87
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 86
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 86
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 85
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 84
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 84
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 82
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 81
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 81
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 80
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 80
Evidence for multiple pairs of vicinal thiols in some proteins 79
Selective modification of Sendai virus hemagglutinin neuraminidase by pyridoxal 5'-phosphate: evidence for an allosteric modulation of neuraminidase activity 78
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 77
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 76
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 76
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 76
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 74
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 74
Anomeric specificity of the neuraminidase from sendai virus 73
Analisi della proteina basica della mielina nel liquor 72
The allosteric site of sendai virus hemagglutinin neuraminidase 72
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 72
Diagnostic value of laboratory tests in Multiple Sclerosis 71
Le beta-esoso-aminidasi liquorali nella sclerosi multipla ed in altri disordini neurologici 69
Allosteric inhibition of the water-soluble C-terminal fragment of Sendai virus neuraminidase 69
Preliminary cheracterization of recombinant hemagglutinin from Mumps virus 69
null 68
null 68
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 68
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 67
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 66
Effect of the substrate on the binding of coenzyme and coenzyme analogues to 6-phosphogluconate dehydrogenase from Candida utilis 66
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 66
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 66
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 65
Interazione della proteina basica della mielina con membrane cellulari 65
Mutual communication of envelope glycoproteins of paramixoviruses 65
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 65
Domain structure of the hemagglutinin-neuraminidase from sendai virus 64
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 63
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 62
The active site of 6-phosphogluconate dehydrogenase. A phosphate binding site and its surroundings 62
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 62
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 62
METABOLOMICS ANALYSIS OF LEISHMANIA PROMASTIGOTES TREATED WITH THE 6-AMINONICOTINAMIDE 62
Biochemical study in adult population with stroke in Ferrara, Fabry disease 62
Totale 9.558
Categoria #
all - tutte 50.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 172
Totale 50.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.466 0 0 0 0 0 0 0 0 203 310 271 682
2019/20202.937 591 95 69 369 145 356 276 291 215 348 128 54
2020/20212.304 202 184 89 251 131 225 118 267 60 328 332 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.208 230 161 54 264 358 297 112 212 251 47 142 80
2023/2024665 113 128 67 36 113 89 25 66 28 0 0 0
Totale 14.528